SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-108983
Filing Date
2021-04-07
Accepted
2021-04-07 17:03:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d49031ddefa14a.htm DEFA14A 16810
2 GRAPHIC g49031dsp020.jpg GRAPHIC 189994
3 GRAPHIC g49031dsp021.jpg GRAPHIC 160650
  Complete submission text file 0001193125-21-108983.txt   501167
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37718 | Film No.: 21812819
SIC: 2834 Pharmaceutical Preparations